CapsoVision receives CE Mark approval for use of CapsoCam Plus System in pediatric patients

Award-winning technology provides 360º imaging, eliminates need for receiver equipment during examination

Today Silicon Valley-based CapsoVision, Inc. announced CE Mark approval for their CapsoCam Plus® System in patients ages 2 and above. It is the only wire-free capsule endoscopy system on the market that provides a full 360° panoramic lateral image of the small bowel mucosa.

“Gastroenterologists and patients have told us that CapsoCam Plus provided them with comfort and convenience compared to other capsule endoscopy systems,” CapsoVision President Johnny Wang said. “Since CapsoCam Plus does not require patients to wear a data recorder like with ordinary capsule endoscopes, these benefits are more pronounced for use with younger patients and their caregivers.”

The incidence of Inflammatory Bowel Disease (IBD) in pediatric patients worldwide is on the rise, particularly in Europe. According to a recent report commissioned by United European Gastroenterology (UEG), childhood onset of IBD now accounts for 20-30% of all IBD cases. Capsule endoscopy is one of the tools that pediatric gastroenterologists use to identify abnormalities of the small bowel that may lead to an IBD diagnosis.

Dr. Salvatore Oliva, pediatric gastroenterologist at the Sapienza University of Rome, Italy, will discuss the use of CapsoCam Plus in patients ages 2 and above at the United European Gastroenterology Week (UEGW) in Barcelona on October 31, 2017 at the CapsoVision exhibit booth and at a Panel Presentation in the evening.

Advertisement

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
Post
You might also like... ×
New AASLD guideline focuses on improving diagnosis, treatment of liver cancer and NAFLD